balsalazide
(XDCNKOBSQURQOZ-UHFFFAOYSA-L)
Structure
- SMILES
- [O-]C(=O)CCNC(=O)c1ccc(cc1)N=Nc1ccc(c(c1)C(=O)O)[O-].O.O.[Na+].[Na+]
- Molecular Formula:
- C17H17N3Na2O8
- Molecular Weight:
- 437.312
- Log P:
- 2.0761
- Hydrogen Bond Acceptor:
- 11
- Hydrogen Bond Donor:
- 4
- TPSA:
- 172.77
- CAS Number(s):
- 150399-21-6
Synonym(s)
1.
balsalazide
2.
5-(carboxyethylcarbamoyl-4-phenylazo)salicylic acid
3.
BX 661A
4.
BX661A
5.
Colazal
6.
Colazide
7.
balsalazide disodium
8.
balsalazine
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Abdominal Pain | FAERS: 6 | US FAERS | |
| 2 | Chest Pain | FAERS: 3 | US FAERS | |
| 3 | Feeling abnormal | FAERS: 3 | US FAERS | |
| 4 | Headache | FAERS: 3 | US FAERS | |
| 5 | Malaise | FAERS: 3 | US FAERS | |
| 6 | Product substitution issue | FAERS: 3 | US FAERS | |
| 7 | Gastrointestinal obstruction | FAERS: 2 | US FAERS | |
| 8 | Guillain-Barre Syndrome | FAERS: 2 | US FAERS | |
| 9 | Hypotension | FAERS: 2 | US FAERS | |
| 10 | Myocarditis | FAERS: 2 | US FAERS | |
| 11 | Nausea | FAERS: 2 | US FAERS | |
| 12 | Neutropenia | FAERS: 2 | US FAERS | |
| 13 | Pain | FAERS: 2 | US FAERS | |
| 14 | Pancreatitis | FAERS: 2 | US FAERS | |
| 15 | Pharmaceutical product complaint | FAERS: 2 | US FAERS | |
| 16 | Vomiting | FAERS: 2 | US FAERS | |
| 17 | Abdominal discomfort | FAERS: 1 | US FAERS | |
| 18 | Abscess | FAERS: 1 | US FAERS | |
| 19 | Acne | FAERS: 1 | US FAERS | |
| 20 | Angioedema | FAERS: 1 | US FAERS | |
| 21 | Anosmia | FAERS: 1 | US FAERS | |
| 22 | Arthralgia | FAERS: 1 | US FAERS | |
| 23 | Arthritis | FAERS: 1 | US FAERS | |
| 24 | Asthma | FAERS: 1 | US FAERS | |
| 25 | Blood glucose decreased | FAERS: 1 | US FAERS | |
| 26 | Blood glucose increased | FAERS: 1 | US FAERS | |
| 27 | Burning sensation | FAERS: 1 | US FAERS | |
| 28 | Chromaturia | FAERS: 1 | US FAERS | |
| 29 | Colitis | FAERS: 1 | US FAERS | |
| 30 | Drug exposure during pregnancy | FAERS: 1 | US FAERS | |
| 31 | Drug ineffective | FAERS: 1 | US FAERS | |
| 32 | Dry skin | FAERS: 1 | US FAERS | |
| 33 | Educational problem | FAERS: 1 | US FAERS | |
| 34 | Ejection Fraction Decreased | FAERS: 1 | US FAERS | |
| 35 | Encephalitis | FAERS: 1 | US FAERS | |
| 36 | Erythema | FAERS: 1 | US FAERS | |
| 37 | Eye irritation | FAERS: 1 | US FAERS | |
| 38 | Fatigue | FAERS: 1 | US FAERS | |
| 39 | Fibromyalgia | FAERS: 1 | US FAERS | |
| 40 | Flatulence | FAERS: 1 | US FAERS | |
| 41 | Foreign body trauma | FAERS: 1 | US FAERS | |
| 42 | Foreign travel | FAERS: 1 | US FAERS | |
| 43 | Gastrointestinal Pain | FAERS: 1 | US FAERS | |
| 44 | Granuloma | FAERS: 1 | US FAERS | |
| 45 | Growth retardation | FAERS: 1 | US FAERS | |
| 46 | Hypersensitivity | FAERS: 1 | US FAERS | |
| 47 | Hypothyroidism | FAERS: 1 | US FAERS | |
| 48 | Hypoxia | FAERS: 1 | US FAERS | |
| 49 | Impaired work ability | FAERS: 1 | US FAERS | |
| 50 | Lethargy | FAERS: 1 | US FAERS | |
| 51 | Lip swelling | FAERS: 1 | US FAERS | |
| 52 | Lymphocytosis | FAERS: 1 | US FAERS | |
| 53 | Medical device complication | FAERS: 1 | US FAERS | |
| 54 | Medication Error | FAERS: 1 | US FAERS | |
| 55 | Neonatal disorder | FAERS: 1 | US FAERS | |
| 56 | Pericarditis | FAERS: 1 | US FAERS | |
| 57 | Pneumonitis | FAERS: 1 | US FAERS | |
| 58 | Post procedural complication | FAERS: 1 | US FAERS | |
| 59 | Pregnancy | FAERS: 1 | US FAERS | |
| 60 | Product difficult to swallow | FAERS: 1 | US FAERS | |
| 61 | Pruritus | FAERS: 1 | US FAERS | |
| 62 | Respiratory distress | FAERS: 1 | US FAERS | |
| 63 | Skin lesion | FAERS: 1 | US FAERS | |
| 64 | Sperm count decreased | FAERS: 1 | US FAERS | |
| 65 | Thrombocytopenia | FAERS: 1 | US FAERS | |
| 66 | Toxicity to various agents | FAERS: 1 | US FAERS | |
| 67 | Unevaluable event | FAERS: 1 | US FAERS | |
| 68 | Vasculitis | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.